Syon Capital LLC Buys Shares of 13,062 Smith & Nephew plc (NYSE:SNN)

Syon Capital LLC purchased a new position in shares of Smith & Nephew plc (NYSE:SNN) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 13,062 shares of the medical equipment provider’s stock, valued at approximately $356,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. CWM LLC raised its stake in Smith & Nephew by 68.6% during the fourth quarter. CWM LLC now owns 954 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 388 shares during the last quarter. Allworth Financial LP grew its holdings in Smith & Nephew by 1,566.2% during the 3rd quarter. Allworth Financial LP now owns 1,133 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 1,065 shares during the period. GAMMA Investing LLC bought a new position in shares of Smith & Nephew in the 4th quarter worth about $53,000. Signaturefd LLC lifted its stake in shares of Smith & Nephew by 31.3% in the 3rd quarter. Signaturefd LLC now owns 5,322 shares of the medical equipment provider’s stock valued at $132,000 after purchasing an additional 1,268 shares during the period. Finally, Seed Wealth Management Inc. bought a new stake in shares of Smith & Nephew during the 4th quarter valued at about $213,000. Institutional investors and hedge funds own 25.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Smith & Nephew from a “buy” rating to a “strong-buy” rating in a report on Friday, March 15th. Three research analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Smith & Nephew presently has a consensus rating of “Moderate Buy”.

Smith & Nephew Stock Up 2.4 %

Shares of NYSE SNN opened at $24.45 on Friday. Smith & Nephew plc has a 12-month low of $21.52 and a 12-month high of $33.08. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.77 and a quick ratio of 0.72. The company’s fifty day simple moving average is $25.99 and its 200 day simple moving average is $25.98.

Smith & Nephew Announces Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Tuesday, April 2nd will be given a dividend of $0.462 per share. The ex-dividend date of this dividend is Monday, April 1st. This represents a dividend yield of 2.8%.

Smith & Nephew Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.